Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

FAT Brands Shares Face Unrelenting Decline

Dieter Jaworski by Dieter Jaworski
November 14, 2025
in Analysis, Consumer & Luxury, Earnings
0
FAT Brands Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

FAT Brands Inc. finds itself navigating turbulent market conditions as its stock continues a significant downward trajectory. Investor confidence has been severely tested following the release of disappointing quarterly earnings and a crucial regulatory filing, with shares dropping nearly 6% in a single trading session. Over the past week, cumulative losses have reached approximately 10%, reflecting growing apprehension among shareholders.

Leadership Changes and Cost Reduction Initiatives

Amid the financial challenges, the company submitted an important proxy statement to the SEC yesterday. This filing confirmed Andrew Wiederhorn’s return to the chief executive officer position in early September. On a positive note, the resolution of legal disputes is projected to generate annual savings of around $30 million. A shareholder meeting scheduled for December 23 will address the election of 14 board directors and management compensation packages.

The executive team has outlined an ambitious recovery strategy. Plans include a capital raise of $75 to $100 million for its Twin Peaks subsidiary, aimed at reducing corporate debt and funding new location development. Combined with suspended dividend payments and savings from settled legal matters, these measures could potentially unlock $65 to $70 million in annual liquidity.

Should investors sell immediately? Or is it worth buying FAT Brands?

Third Quarter Performance Disappoints

The financial results for the third quarter of 2025, released on November 5, revealed substantial challenges. FAT Brands reported a net loss of $59.45 million, significantly wider than the comparable period last year. Earnings per share plummeted to negative $3.39. Even revenue figures of $140 million fell below expectations and demonstrated a year-over-year decrease. Since the beginning of the month, the company’s market valuation has eroded by roughly one-third.

Expansion Plans Face Headwinds

The company’s growth initiatives have encountered implementation delays. Rather than the initially projected 100 new restaurant openings for this year, FAT Brands now anticipates launching only 80 locations. Franchisee-related postponements have tempered the pace of expansion. However, the development pipeline remains substantial, with approximately 900 planned sites scheduled to open over the next five to seven years. This long-term growth strategy could potentially contribute $50 to $60 million in additional EBITDA once fully realized.

The critical question facing investors is whether FAT Brands can successfully execute its debt restructuring efforts and complete the proposed capital infusion. The coming months will determine if market participants maintain faith in the restaurant chain’s turnaround strategy as the stock’s performance continues to reflect these fundamental challenges.

Ad

FAT Brands Stock: Buy or Sell?! New FAT Brands Analysis from February 7 delivers the answer:

The latest FAT Brands figures speak for themselves: Urgent action needed for FAT Brands investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

FAT Brands: Buy or sell? Read more here...

Tags: FAT Brands
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Next Post
Newmont Mining Stock

Gold Producer Newmont Surges as Investors Seek Safe Havens

iShares® Gold Trust Micro Stock

Gold's Quiet Ascent Continues Through Micro-ETF Channel

Ishares Msci Acwi ETF Stock

Global Stock Rally Powers iShares MSCI ACWI ETF to Strong Gains

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com